Yes, drug quality audits in Japan include a review of pharmacovigilance systems. These audits assess compliance with Good Pharmacovigilance Practices (GVP) to ensure drug safety and efficacy. The process involves evaluating adverse event reporting, risk management, and monitoring systems to maintain high standards in pharmaceutical quality and patient safety.